2327. Monitoring Of Cytomegalovirus Infection In Non-Transplant Pediatric Leukemia During Chemotherapy
Session: Poster Abstract Session: Pediatric Virology
Saturday, October 7, 2017
Room: Poster Hall CD
  • poster IDweek 54x36.pdf (1.1 MB)
  • Background: Cytomegalovirus (CMV) infection is a significant cause of morbidity and mortality in post-transplant setting, however, it has been increasingly recognized in non-transplant pediatric leukemia. We postulate that CMV reactivation may occur during chemotherapy, without any intervention, finally it can progress to CMV end organ diseases. This study was aimed to assess the prevalence and associated factors of CMV infection in pediatric leukemic patients.

    Methods: A cross-sectional study involving 50 pediatric leukemic patients receiving chemotherapy at Ramathibodi Hospital, Bangkok, Thailand from December 2015 to December 2016 was performed. Plasma CMV viral load quantified by the Abbott RealTime CMV assay (Abbott Molecular Inc., Des Plaines, IL, USA) was monitored in different phases of chemotherapy; post-induction, post-consolidation, post-intensification, and maintenance.

    Results: Of 50 patients enrolled, 141 blood tests were evaluated. The overall prevalence of CMV DNAemia (≥ 31.2 IU/ml) and high-level CMV DNAemia (≥ 1,500 IU/ml) were 52.0% (26 of 50) and 16.0% (8 of 50), respectively. All patients with high-level CMV DNAemia were in maintenance phase of chemotherapy. One patient had CMV retinitis, while the rest had no end organ diseases. Lymphocyte count increase was significantly associated with protection from high-level CMV DNAemia, odds ratio 0.997, P = 0.02. The ROC curve analysis identified a cut-off value of 798 /μL of absolute lymphocyte count (ALC) as a discriminator for the presence of high-level CMV DNAemia, AUC 0.756, 95% CI 0.645-0.867, P = 0.001, with 88.9% sensitivity and 50.4% specificity.

    Conclusion: In pediatric leukemia, non-transplant setting, CMV infection predominantly occurred during maintenance phase of chemotherapy. Lower ALC was significantly associated with high-level CMV DNAemia. We recommend that CMV infection surveillance by a quantitative CMV DNA PCR be considered during maintenance phase in pediatric leukemic patients with ALC < 800 /𝜇L.

    Nonthapan Phasuk, MD1,2, Nopporn Apiwattanakul, MD, PhD1, Chonnamet Techaseansiri, MD1 and Usanarat Anurathapan, MD1, (1)Department of Pediatrics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand, (2)School of Medicine, Walailak University, Nakhon Si Thammarat, Thailand


    N. Phasuk, None

    N. Apiwattanakul, None

    C. Techaseansiri, None

    U. Anurathapan, None

    See more of: Pediatric Virology
    See more of: Poster Abstract Session

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.